Starpharma Holdings Ltd (SPHRY)
0.6993
-0.02
(-2.88%)
USD |
OTCM |
Jun 14, 16:00
Starpharma Holdings Enterprise Value: 9.055M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 9.055M |
| June 13, 2024 | 9.91M |
| June 12, 2024 | 9.91M |
| June 11, 2024 | 9.91M |
| June 10, 2024 | 9.91M |
| June 07, 2024 | 9.91M |
| June 06, 2024 | 9.91M |
| June 05, 2024 | 9.496M |
| June 04, 2024 | 11.14M |
| June 03, 2024 | 14.67M |
| May 31, 2024 | 14.67M |
| May 30, 2024 | 14.67M |
| May 29, 2024 | 7.304M |
| May 28, 2024 | 10.97M |
| May 24, 2024 | 10.97M |
| May 23, 2024 | 13.82M |
| May 22, 2024 | 13.82M |
| May 21, 2024 | 13.62M |
| May 20, 2024 | 13.62M |
| May 17, 2024 | 10.01M |
| May 16, 2024 | 10.01M |
| May 15, 2024 | 10.01M |
| May 14, 2024 | 10.01M |
| May 13, 2024 | 10.01M |
| May 10, 2024 | 9.957M |
| Date | Value |
|---|---|
| May 09, 2024 | 9.957M |
| May 08, 2024 | 9.957M |
| May 07, 2024 | 9.957M |
| May 06, 2024 | 16.00M |
| May 03, 2024 | 11.14M |
| May 02, 2024 | 11.14M |
| May 01, 2024 | 17.32M |
| April 30, 2024 | 17.32M |
| April 29, 2024 | 18.15M |
| April 26, 2024 | 18.15M |
| April 25, 2024 | 18.15M |
| April 24, 2024 | 15.26M |
| April 23, 2024 | 15.26M |
| April 22, 2024 | 15.26M |
| April 19, 2024 | 17.32M |
| April 18, 2024 | 17.32M |
| April 17, 2024 | 17.80M |
| April 16, 2024 | 15.68M |
| April 15, 2024 | 15.68M |
| April 12, 2024 | 15.68M |
| April 11, 2024 | 15.68M |
| April 10, 2024 | 15.68M |
| April 09, 2024 | 15.68M |
| April 08, 2024 | 15.68M |
| April 05, 2024 | 15.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
7.304M
Minimum
May 29 2024
719.61M
Maximum
Feb 16 2021
225.88M
Average
242.58M
Median
Jun 01 2020
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 3.883M |
| Immutep Ltd | -- |
| Opthea Ltd | 4.905M |
| Mesoblast Ltd | -- |
Enterprise Value Related Metrics
| Earnings Yield | -21.14% |
| Normalized Earnings Yield | -21.14 |